Cargando…

A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderly

Chronic constipation is a common disorder in the general population, with higher prevalence in the elderly, and is associated with worse quality of life and with greater health care utilization. Lubiprostone is an intestinal type-2 chloride channel activator that increases intestinal fluid secretion...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gras-Miralles, Beatriz, Cremonini, Filippo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578442/ https://www.ncbi.nlm.nih.gov/pubmed/23439964 http://dx.doi.org/10.2147/CIA.S30729

Ejemplares similares

Lubiprostone: a novel treatment for chronic constipation
por: Lacy, Brian E, et al.
Publicado: (2008)

The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation
por: Pennington, Becky, et al.
Publicado: (2018)

Lubiprostone for the Treatment of Adult Women with Irritable Bowel Syndrome with Constipation
por: Soubra, Mahmoud, et al.
Publicado: (2012)

Factors associated with long-term efficacy of lubiprostone for chronic constipation
por: Morise, Takashi, et al.
Publicado: (2023)

Effectiveness and safety of lubiprostone after switching from stimulant laxatives in elderly patients with chronic constipation
por: Maruyama, Masaki, et al.
Publicado: (2023)

Lubiprostone for the Treatment of Clozapine-Induced Constipation: A Case Series
por: Torrico, Tyler J, et al.
Publicado: (2022)

Analysis of Nausea in Clinical Studies of Lubiprostone for the Treatment of Constipation Disorders
por: Cryer, Byron, et al.
Publicado: (2017)

Lubiprostone in the treatment of chronic idiopathic constipation: an update on health-related quality of life and patient-reported outcomes
por: Hayat, Maham, et al.
Publicado: (2019)

Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States
por: Nag, Arpita, et al.
Publicado: (2020)

Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndrome
por: Lunsford, Tisha N, et al.
Publicado: (2010)

A Randomized Study of Lubiprostone for Opioid-Induced Constipation in Patients with Chronic Noncancer Pain
por: Cryer, Byron, et al.
Publicado: (2014)

Effects of Lubiprostone, an Intestinal Secretagogue, on Electrolyte Homeostasis in Chronic Idiopathic and Opioid-induced Constipation
por: Rao, Satish S.C., et al.
Publicado: (2021)

Capsule and Sprinkle Formulations of Lubiprostone Are Not Biologically Similar in Patients with Functional Constipation
por: Adams, Atoya, et al.
Publicado: (2021)

A Randomized, Placebo-Controlled Trial of Lubiprostone for Opioid-Induced Constipation in Chronic Noncancer Pain
por: Jamal, M Mazen, et al.
Publicado: (2015)

Safety of Lubiprostone in Pediatric Patients With Functional Constipation: A Nonrandomized, Open-Label Trial
por: Hussain, Sunny Z., et al.
Publicado: (2021)

Effect of Lubiprostone on Urinary Protein Excretion: A Report of Two IgA Nephropathy Patients with Chronic Constipation
por: Takeshita, Mitsuhide, et al.
Publicado: (2019)

Stimulation of Mucin, Mucus, and Viscosity during Lubiprostone in Patients with Chronic Constipation may Potentially Lead to Increase of Lubrication
por: Majewski, Marek, et al.
Publicado: (2014)

Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation
por: Chang, L., et al.
Publicado: (2016)

Long-Term Safety and Effectiveness of Lubiprostone, a Chloride Channel (ClC-2) Activator, in Patients with Chronic Idiopathic Constipation
por: Lembo, Anthony J., et al.
Publicado: (2011)

Role of Lubiprostone on Gastrointestinal Motility
por: Jun, Jae Yeoul
Publicado: (2013)

Clubbed Digits Presumably Caused by Lubiprostone
por: Kawamoto, Ryuichi, et al.
Publicado: (2021)

Chronic constipation in the elderly: a primer for the gastroenterologist
por: De Giorgio, Roberto, et al.
Publicado: (2015)

Lubiprostone plus polyethylene glycol electrolyte lavage solution (PEG-ELS) versus PEG-ELS for bowel preparation in chronic constipation: a randomized controlled trial
por: Tangvoraphonkchai, K., et al.
Publicado: (2023)

Epidemiology and management of chronic constipation in elderly patients
por: Vazquez Roque, Maria, et al.
Publicado: (2015)

Lubiprostone Stimulates Duodenal Bicarbonate Secretion in Rats
por: Mizumori, Misa, et al.
Publicado: (2009)

Lubiprostone stimulates small intestinal mucin release
por: De Lisle, Robert C
Publicado: (2012)

Managing atrial fibrillation in the elderly: critical appraisal of dronedarone
por: Trigo, Paula, et al.
Publicado: (2012)

Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia
por: DeRemer, David L, et al.
Publicado: (2011)

Lubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype
por: De Lisle, Robert C, et al.
Publicado: (2010)

Expert consensus on the assessment and treatment of chronic constipation in the elderly
por: Zheng, Songbai, et al.
Publicado: (2018)

Chronic Constipation in the Elderly Patient: Updates in Evaluation and Management
por: Mari, Amir, et al.
Publicado: (2020)

Update on the management of constipation in the elderly: new treatment options
por: Rao, Satish SC, et al.
Publicado: (2010)

OnabotulinumtoxinA for chronic migraine: a critical appraisal
por: Gooriah, Rubesh, et al.
Publicado: (2015)

Critical appraisal of ramelteon in the treatment of insomnia
por: Mets, Monique AJ, et al.
Publicado: (2010)

Review of Treatment Options for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation
por: Patel, Sarah, et al.
Publicado: (2021)

Chronic Constipation
Publicado: (1928)

A critical appraisal of ibrutinib in the treatment of mantle cell lymphoma and chronic lymphocytic leukemia
por: Tucker, David L, et al.
Publicado: (2015)

Critical appraisal of bevacizumab in the treatment of ovarian cancer
por: Yoshida, Hiroyuki, et al.
Publicado: (2015)

Critical appraisal of paroxetine for the treatment of vasomotor symptoms
por: Carroll, Dana G, et al.
Publicado: (2015)

The Treatment of Chronic Constipation
Publicado: (1892)

Cannot write session to /tmp/vufind_sessions/sess_s8jqbftu5uqfm6g8irvq30rr84